Dr Yvette Kazungu

Biography

Yvette Kazungu is a postdoctoral researcher in molecular virology with a background in ribonucleic acid virus-host interactions and cross-talks with innate immunity. More recently, her research focus has veered into translational virology research including in vivo work and drug screening against viruses of clinical importance.

This includes a recent collaborative project which tested small antiviral compounds against SARS-CoV-2 in a humanised mouse model and established the immunophenotype profiles after treatment.

In her current project, Yvette uses reverse genetics and large scale random codon re-encoding to attenuate viruses and profile the differences in immune responses to infection and interventions in vivo.

Selected research publications

The CCR2 inflammatory pathway is a target for improving severe disease and pulmonary inflammation in experimental COVID-19 – Journal: Virulence – Published: 15th July 2026

Inhibitors of protein glycosylation are active against the coronavirus severe acute respiratory syndrome coronavirus sars-cov-2 – Journal: Viruses – Published: 30th April 2021

Variant analysis of the sporozoite surface antigen gene reveals that asymptomatic cattle from wildlife-livestock interface areas in northern Tanzania harbour buffalo-derived T. parva – Journal: Parasitology Research – Published: 3rd October 2020

Viral priming of cell intrinsic innate antiviral signaling by the unfolded protein response – Journal: Nature Communications – Published: 1st December 2019

View more publications